Wenliang Chen | Clinical medicine | Best Researcher Award

Assoc. Prof. Dr. Wenliang Chen | Clinical medicine | Best Researcher Award

Assoc. Prof. Dr. Wenliang Chen, Shanxi Medical University, China

Dr. Wenliang Chen completed his Bachelor’s degree in Clinical Medicine at Shanxi Medical University in 1996. He further pursued a Masterโ€™s degree in General Surgery at the same institution, graduating in 2002. To deepen his expertise, he obtained a Doctor of Medicine in General Surgery from the prestigious Chinese PLA General Hospital in 2023. His academic journey reflects a steadfast commitment to advancing surgical knowledge and practices, supported by specialized training in Surgical ICU and Gastrointestinal Surgery at leading hospitals in China and the USA.

Publication Profile

Orcid

Education ๐ŸŽ“

Dr. Wenliang Chen completed his Bachelor’s degree in Clinical Medicine at Shanxi Medical University in 1996. He further pursued a Masterโ€™s degree in General Surgery at the same institution, graduating in 2002. To deepen his expertise, he obtained a Doctor of Medicine in General Surgery from the prestigious Chinese PLA General Hospital in 2023. His academic journey reflects a steadfast commitment to advancing surgical knowledge and practices, supported by specialized training in Surgical ICU and Gastrointestinal Surgery at leading hospitals in China and the USA.

Experience ๐Ÿ’ผ

Dr. Chenโ€™s career spans more than 20 years, beginning as a General Surgeon at the Second Hospital of Shanxi Medical University. His experience includes advanced surgical training at Beijing Chaoyang Hospital and Peking University People’s Hospital. Additionally, he gained international insights as a Visiting Scholar at Duke University Medical Center and The Ohio State University. Since 2015, he has been a prominent figure in gastrointestinal and minimally invasive surgeries. His dedication to patient care and academic mentorship has greatly contributed to the institutionโ€™s medical excellence.

Awards and Honors ๐Ÿ†

Assoc. Prof. Dr. Wenliang Chen has earned numerous accolades for his contributions to the field of surgery. His pioneering efforts in obesity and diabetes surgery in Shanxi Province and his successful laparoscopic Nissen fundoplication for gastroesophageal reflux disease have established him as a surgical innovator. Furthermore, his active roles in national and provincial medical committees, including the Colorectal Cancer Committee and the Gastrointestinal Surgery Committee, exemplify his leadership and dedication to medical advancement.

Research Focus ๐Ÿ”Ž

Dr. Chen’s research primarily focuses on the diagnosis and surgical treatment of gastrointestinal diseases. He has led significant studies, notably as Principal Investigator on the regulatory mechanism of LncRNA PVT1 in gastric cancer proliferation and invasion. His interest in minimally invasive surgeries has led to advancements in laparoscopic techniques, benefiting patient recovery and surgical outcomes. His dedication to translational research has strengthened the clinical application of innovative treatments, contributing to the advancement of gastrointestinal oncology and metabolic disease management.

Publication Top Notes

๐Ÿ“„ Innovative Approaches to Managing Postoperative Complications in Laparoscopic Sleeve Gastrectomy: A Scoping Review (2024) | ๐Ÿ› Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A | ๐Ÿ”— DOI: 10.1089/lap.2024.0227

๐Ÿ“„ Oxidative stress-related patterns determination for establishment of prognostic models, and characteristics of tumor microenvironment infiltration (2022) | ๐Ÿ› Frontiers in Surgery | ๐Ÿ”— DOI: 10.3389/fsurg.2022.1013794

๐Ÿ“„ Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer (2022) | ๐Ÿ› Frontiers in Immunology | ๐Ÿ”— DOI: 10.3389/fimmu.2022.962056

๐Ÿ“„ Efficacy and safety of over-the-scope clips for colorectal leaks and fistulas: a pooled analysis (2022) | ๐Ÿ› Minimally Invasive Therapy & Allied Technologies | ๐Ÿ”— DOI: 10.1080/13645706.2021.2010218

๐Ÿ“„ LncRNA SNHG6 inhibits autophagy of gastric carcinoma cells via PI3K/AKT/mTOR signaling pathway (2022) | ๐Ÿ› American Journal of Translational Research | ๐Ÿ”— PMID: 35702105

๐Ÿ“„ The Role of lncRNA PVT1 and hsa-miR-30a-3p in the Development of Gastric Cancer (2022) | ๐Ÿ› Annals of Clinical and Laboratory Science | ๐Ÿ”— PMID: 35414508

๐Ÿ“„ Laparoscopy for Hepatolithiasis: Biliary Duct Exploration with Primary Closure Versus T-Tube Drainage (2020) | ๐Ÿ› Journal of Laparoendoscopic & Advanced Surgical Techniques | ๐Ÿ”— DOI: 10.1089/lap.2020.0081

๐Ÿ“„ A Comparison of the Relative Safety and Efficacy of Laparoscopic Choledochotomy with Primary Closure and Endoscopic Treatment for Bile Duct Stones in Patients with Cholelithiasis (2020) | ๐Ÿ› Journal of Laparoendoscopic & Advanced Surgical Techniques | ๐Ÿ”— DOI: 10.1089/lap.2019.0775

 

Haojie Shan | Medicine | Best Researcher Award

Haojie Shan | Medicine | Best Researcher Award

Resident Surgeon at Shanghai Sixth Peopleโ€™s Hospital Affiliated to Shanghai Jiao Tong University School, China.

Dr. Haojie Shan is a dedicated resident surgeon specializing in orthopaedics at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. With a strong clinical and research foundation, Dr. Shan is passionate about advancing orthopaedic treatments, focusing on challenging areas such as osteonecrosis of the femoral head, bone immunity, and regeneration. His contributions to orthopaedics have been recognized through multiple prestigious awards, highlighting his commitment to innovation. Dr. Shanโ€™s blend of clinical expertise and research excellence positions him as an emerging leader in orthopaedics, driven to enhance patient care and develop novel medical solutions.

Publication Profile

Scopus

Education

Dr. Shan completed his Ph.D. in Surgery (Orthopaedics) in 2023 at Shanghai Jiao Tong University, where he also earned his MD in 2020. He first obtained his Bachelor of Science in Clinical Medicine from Henan University in 2017. Each stage of his education has been marked by rigorous training, both in clinical practice and research, equipping him with a comprehensive understanding of orthopaedic medicine. This academic progression underscores Dr. Shanโ€™s commitment to mastering complex medical challenges, particularly in his chosen field of orthopaedics, and provides a strong foundation for his clinical and research career.

Professional Experience

Currently, Dr. Shan is a resident surgeon in orthopaedics at Shanghai Sixth People’s Hospital. In this role, he has gained practical experience managing complex orthopaedic cases, with a focus on surgical techniques and postoperative care. His position at this leading hospital allows him to integrate his research insights with clinical practice, enhancing patient care with innovative approaches. His exposure to diverse cases has refined his skills in addressing issues like bone regeneration and infection control, which align with his research interests. Dr. Shanโ€™s experience exemplifies his dedication to combining clinical expertise with research-driven improvements in orthopaedic care.

Research Focus

Dr. Shan’s research focuses on osteonecrosis of the femoral head, bone immunity, bone regeneration, and biomedical materials. His work seeks to address significant challenges in orthopaedic surgery, such as restoring bone function and preventing infection in complex cases. Dr. Shan is particularly interested in innovative treatments that promote healing and enhance patient outcomes. His research on bone and soft tissue infection and immunity explores the interactions between implants and the bodyโ€™s immune response. Through his investigations, Dr. Shan aims to bridge scientific discovery and clinical application, advancing orthopaedic treatment methods and expanding therapeutic options in the field.

Awards and Honors

Dr. Shan has received multiple prestigious awards, reflecting his contributions to orthopaedics and medical innovation. In 2024, he won the Gold Award in the Shanghai Division and the National Silver Award at the International Innovation Competition for College Students in China. Additionally, he earned First Prize in the Rehabilitation Medicine and Engineering Innovation Competition (2023) and accolades for his papers at major conferences. His achievements also include third-place awards in the China Medical Device Innovation Competition and the Shanghai Orthopedics Annual Meeting. These recognitions underscore Dr. Shan’s dedication to advancing orthopaedic science and patient care.

Conclusion

Overall, Dr. Haojie Shan demonstrates strong qualifications for the “Best Researcher Award” based on his academic background, innovative research, and significant recognition within orthopaedics. Enhancing international visibility through collaborations and publications could further elevate his standing. Given his notable achievements and ongoing impact, he is a well-qualified candidate for the award.

Publication Top Notesย 

Title: A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm
Authors: Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X.
Year: 2025
Journal: Carbohydrate Polymers, 347, 122723
Citations: 0

Title: Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections
Authors: Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X.
Year: 2024
Journal: Aggregate
Citations: 0

Title: An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing
Authors: Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C.
Year: 2024
Journal: Small Methods
Citations: 0

Title: Scd-1 deficiency promotes the differentiation of CD8+ T effector
Authors: Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X.
Year: 2024
Journal: Frontiers in Cellular and Infection Microbiology, 14, 1325390
Citations: 1

Title: Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways
Authors: Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X.
Year: 2023
Journal: Cell Proliferation, 56(11), e13485
Citations: 4

Title: Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1ฮฑ
Authors: Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T.
Year: 2023
Journal: Advanced Therapeutics, 6(3), 2200164
Citations: 2

Title: The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis
Authors: Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(4), pp. 240โ€“245
Citations: 0

Title: Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination
Authors: Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(3), pp. 197โ€“203
Citations: 0

Title: Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis
Authors: Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X.
Year: 2022
Journal: mSystems, 7(4)
Citations: 9